Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...

Hemorrhagic Stroke ll: Pathophysiology

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Post pulmonary embolism syndrome following paediatric pulmonary embolism: a multicentre, retrospective cohort study.

The Lancet. Haematology·2026

Same author

Postpartum well-being in hemophilia carriers and women with von Willebrand disease: insights from patient-reported outcome measures.

Research and practice in thrombosis and haemostasis·2026

Same author

ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism.

Blood advances·2026

Same author

Systematic review on the design and methodology of the pediatric direct oral anticoagulant clinical trials for thrombosis prevention: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis.

Journal of thrombosis and haemostasis : JTH·2026

Same author

Higher-dosed clotting factor prophylaxis fails to reduce postpartum hemorrhage in women with von Willebrand disease: findings from the observational PRegnancy and Inherited bleeding DisordErS study.

Journal of thrombosis and haemostasis : JTH·2026

Same author

A qualitative study on the impact of hemophilia on sexual functioning and well-being in Dutch men.

Journal of patient-reported outcomes·2025

Search research articles

Related Experiment Video

Updated: May 30, 2026

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

The bleeding child. Part I: primary hemostatic disorders.

C Heleen van Ommen¹, Marjolein Peters

¹Department of Pediatric Hematology, Emma Children's Hospital AMC, Meibergdreef 9, AZ, Amsterdam, The Netherlands. c.h.vanommen@amc.nl

European Journal of Pediatrics

|July 30, 2011

Summary

Diagnosing childhood mucocutaneous bleeding involves a thorough history and physical exam. Initial tests rule out common disorders, followed by platelet function analysis if needed.

More Related Videos

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Related Experiment Videos

Last Updated: May 30, 2026

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Area of Science:

Pediatric Hematology
Hemostasis and Thrombosis

Background:

Mucocutaneous bleeding is a frequent pediatric concern.
Potential causes include vascular issues, von Willebrand disease, thrombocytopenia, and platelet dysfunction.

Purpose of the Study:

To outline an effective diagnostic approach for childhood mucocutaneous bleeding.
To guide laboratory evaluation based on clinical presentation.

Main Methods:

Detailed bleeding history and physical examination are crucial initial steps.
Laboratory evaluation includes complete blood count, peripheral blood smear, mean platelet volume, and von Willebrand factor (VWF) assays.
Platelet aggregation tests are performed after excluding thrombocytopenia and von Willebrand disease.

Main Results:

Initial tests help differentiate normal from abnormal bleeding.
Exclusion of thrombocytopenia and von Willebrand disease directs further testing towards platelet function.
Specific tests like platelet secretion assays and flow cytometry confirm diagnoses.

Conclusions:

A systematic diagnostic strategy is essential for identifying the cause of bleeding in children.
Early laboratory evaluation and targeted testing optimize diagnostic accuracy.